Last financial report (EOFY) shows they have ~$9M current assets. Running at ~$5M loss a year at moment (>60% of annual expenses are R&D). They have arrangements with GE which is revenue generating. Share price was penalized heavily due to recent trials for lung fibrosis. I cannot advise on why you should invest, but I am sure I saw you pop up here previously (I could be wrong). Anyways back to the day job.
1AD Price at posting:
10.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)